Back

Switching from vitamin k antagonists to novel oral anticoagulants: predictors and outcomes.

2 March 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 2 - Cardiovascular Pharmacotherapy Anticoagulants ACVC Premium Access Acute Cardiovascular Care 2019

About the speaker

Photo
Doctor Ana Marques

Hospital Garcia de Orta, Almada (Portugal)

6 More presentations in this session

Presentation thumbnail
Comparing the efficacy of tranexamic acid to aprotinin in open heart surgery: A systematic review and meta-analysis
Doctor S. Salahia (Cairo, EG)
Presentation thumbnail
Predictors of adverse events occurrence in patients under vitamin K antagonists
Doctor A. Marques (Almada, PT)
Abstract Slides
Presentation thumbnail
A delicate balance
Doctor M. Coutinho Cruz (Lisbon, PT)
Abstract Slides
Presentation thumbnail
Non-valvular atrial fibrillation (AF) and coronary artery disease with percutaneous revascularisation: safety of triple therapy with dabigatran
Doctor M. Cano-Garcia (Malaga, ES)
Abstract Slides
Presentation thumbnail
Long-term mortality in TakoTsubo patients treated with different antiaggregation therapy
Doctor E. Pogran (Vienna, AT)

Access the full session

Session thumbnail
Poster Session 2 - Cardiovascular Pharmacotherapy

The Event

Event poster

Acute Cardiovascular Care 2019

2 March - 4 March 2019
You may be interested in
thumbnail
Congress Presentation
State-of-the-art lecture on pharmacotherapy for acute coronary syndromes
thumbnail
Webinar
Antithrombotic treatment for dual pathway inhibition in cardiovascular disease patients
thumbnail
Congress Presentation
State-of-the-art lecture on adjunctive antiplatelet therapy for patients undergoing percutaneous coronary intervention

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources